S. Korean biotech firms in race for coronavirus treatment, vaccine
May 27, 2020
South Korean pharmaceutical companies have joined the global race to develop a vaccine for the novel coronavirus, but none of them have received approval for clinical trials for a vaccine or treatment candidates from the country's drug safety agency. Celltrion Inc., a major pharmaceutical giant, has announced that it plans to develop a "super antibody" candidate that can help prepare for potential future pandemics. Celltrion was earlier selected as a preferred developer for a monoc